Use of Reverse Phase Protein Arrays to Identify Biomarkers of Response to PI3K/mTOR Inhibitors in Ovarian Cancer Models

被引：0
|
作者：
Tashkandi, G. [1 ]
Mullen, P. [2 ]
Goltsov, A. [3 ]
Bown, J. L. [3 ]
Harrison, D. J. [2 ]
Langdon, S. P. [1 ]
机构：
[1] Univ Edinburgh, Inst Genet & Mol Med, Div Pathol, Edinburgh, Midlothian, Scotland
[2] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland
[3] Univ Abertay, CRISP, Dundee, Scotland
来源：
JOURNAL OF PATHOLOGY | 2013年 / 231卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：25 / 25
页数：1
相关论文
共 50 条
  • [31] REDUCED CANCER CELL SENSITIVITY TO TUMOR TREATING FIELDS (TTFIELDS) THROUGH ACTIVATION OF THE PI3K/AKT/MTOR SIGNALING PATHWAY CAN BE MITIGATED USING PI3K INHIBITORS OR PI3K/MTOR DUAL INHIBITORS
    Klein-Goldberg, Anat
    Voloshin, Tali
    Zemer-Tov, Efrat
    Paz, Rom
    Koren, Lilach
    Wainer-Katsir, Kerem
    Volodin, Alexandra
    Koltun, Bella
    Brant, Boris
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    NEURO-ONCOLOGY, 2021, 23 : 84 - 84
  • [32] PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
    Li, HaiXia
    Zeng, JianFang
    Shen, Keng
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 290 (06) : 1067 - 1078
  • [33] The PI3K/Akt/mTOR pathway in ovarian cancer: therapeutic opportunities and challenges
    Cheaib, Bianca
    Auguste, Aurelie
    Leary, Alexandra
    CHINESE JOURNAL OF CANCER, 2015, 34 (01) : 4 - 16
  • [34] PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
    HaiXia Li
    JianFang Zeng
    Keng Shen
    Archives of Gynecology and Obstetrics, 2014, 290 : 1067 - 1078
  • [35] Targeting PI3K/mTOR signaling in cancer
    Arcaro, Alexandre
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [36] Treatment of Breast Cancer Using Multistage Delivery of PI3K/mTOR Inhibitors
    Blanco, E.
    Sangai, T.
    Martinez, J. O.
    Meric-Bernstam, F.
    Ferrari, M.
    CANCER RESEARCH, 2010, 70
  • [37] Potential Value and Limitation of Dual Inhibitors of PI3K and mTOR in the Treatment of Cancer
    Chen, Jiezhong
    CURRENT CANCER DRUG TARGETS, 2013, 13 (02) : 117 - 120
  • [38] Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention
    Roudsari, Nazanin Momeni
    Lashgari, Naser-Aldin
    Momtaz, Saeideh
    Abaft, Shaghayegh
    Jamali, Fatemeh
    Safaiepour, Pardis
    Narimisa, Kiyana
    Jackson, Gloria
    Bishayee, Anusha
    Rezaei, Nima
    Abdolghaffari, Amir Hossein
    Bishayee, Anupam
    PHARMACEUTICS, 2021, 13 (08)
  • [39] PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress
    Wu, P.
    Hu, Y-Z
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (35) : 4326 - 4341
  • [40] Phytochemicals as PI3K/Akt/mTOR Inhibitors and Their Role in Breast Cancer Treatment
    Narayanankutty, Arunaksharan
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2020, 15 (03) : 188 - 199
12345